95260 ⎘
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
HETEROCYCLIC COMPOUND AND USE THEREOF
#1802Heterocyclic compound and use thereof
#1803Combination of isoindolinone derivatives with SGI-110
#1804Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
#1805Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
#1806Delta-opioid receptor agonists
#1807Compounds for treating proliferative diseases
#1808Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
#1809Redundant power line control systems
#1810Orthoester compositions for affinity purification of oligonucleotides
#1811Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors
#1812Compounds, compositions, and methods for increasing CFTR activity
#1813Substituted pyrimidines, pharmaceutical compositions and therapeutic methods thereof
#1814PHOTO-SWITCHABLE CHEMICAL INDUCERS OF DIMERIZATION FOR CONTROL OF PROTEIN FUNCTION IN CELLS BY LIGHT
#1815Compound used as autophagy regulator, and preparation method therefor and uses thereof
#1816Use of physiological cooling active ingredients, and compositions comprising such active ingredients
#1817PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#1818PPAR agonists
#1819CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
#1820CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING
#1821Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibitor and antitumor agents
#1822HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#1823Substituted isoquionline derivatives as immunomudulators
#1824Orthoester compositions for affinity purification of oligonucleotides
#1825Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative
#1826SELECTIVE MATRIX METALLOPROTEINASE-13 INHIBITORS
#18276-aminoisoquinoline compounds
#1828Compounds
#1829NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE
#1830Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists
#1831HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#1832Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof
#1833Histone demethylase inhibitors
#1834HETEROCYCLIC SMALL MOLECULE MODULATORS OF HUMAN STING
#1835Method of Treating or Inhibiting Malaria
#1836Aryl-or heteroaryl-substituted benzene compounds
#1837Bromodomain inhibitors
#1838Stilbene derivative and preparation method thereof
#1839Small molecule modulators of human sting
#1840ANTIBACTERIAL THERAPEUTICS AND PROPHYLACTICS
#1841N/O-linked Degrons and Degronimers for protein degradation
#1842Compounds and their uses as ACC inhibitors
#1843COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
#1844Substituted indole Mcl-1 inhibitors
#1845Hexamethylindanes
#1846Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide
#1847Indazole compound for use in inhibiting kinase activity, composition and application thereof
#1848Inhibitors of CXCR2
#1849Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
#1850Trioxolane agents
#1851Human helicase DDX3 inhibitors as therapeutic agents
#18522-(4-CHLOROPHENOXY)-N-((1 -(2-(4-CHLOROPHENOXY)ETHYNAZETIDIN-3-YL)METHYL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES
#1853SMALL MOLECULE MODULATORS OF HUMAN STING
#1854METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C
#1855Azaquinoline derivatives
#1856Dual mechanism inhibitors for the treatment of disease
#1857Pyrazole derivatives for the treatment of cystic fibrosis
#1858AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS
#1859Farnesoid X receptor agonists and uses thereof
#1860FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#18612,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
#1862Hepatitis B capsid assembly modulators
#1863Picolinamide compounds with fungicidal activity
#1864Methods for identifying and modulating co-occurant cellular phenotypes
#1865Substituted piperidine compound and use thereof
#1866Modulators of indoleamine 2,3-dioxygenase
#1867Modulators of ATP-binding cassette transporters
#1868LIVER X RECEPTORS (LXR) MODULATORS
#1869Modulation of Bacterial Quorum Sensing With Synthetic Ligands
#1870DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#1871COMPOUNDS AND METHODS FOR TREATING CANCER, NEUROLOGICAL DISORDERS, ETHANOL WITHDRAWAL, ANXIETY, DEPRESSION, AND NEUROPATHIC PAIN
#1872FUSED-BICYCLIC ARYL QUINOLINONE DERIVATIVES AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS
#1873Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
#1874EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
#18752,3-dihydroisoindole-1-carboxamides useful as ROR-gamma modulators
#1876Methods for treating Huntington's disease
#1877Cardiac sarcomere inhibitors
#1878Organic compound and organic electroluminescence device using the same
#1879Inhibitors of the fibroblast growth factor receptor
#1880PKM2 modulators and methods for their use
#1881Carbon monoxide releasing norbornenone compounds
#1882Sulfur derivatives as chemokine receptor modulators
#1883SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#1884Controlling zones of electronic devices associated with power lines
#1885Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
#1886Aryl cyclopropyl-amino-isoquinolinyl amide compounds
#1887Tricyclic spiro compound
#1888Carboxylic acid derivative as ATR receptor antagonist
#1889Inhibitors of integrated stress response pathway
#18904,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
#1891Substituted β-lapachones for treating cancer
#1892CRMP2 sumoylation inhibitors and uses thereof
#1893Compounds and compositions for treating conditions associated with NLRP activity
#1894TRIAZINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#1895Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof
#1896Small molecule regulators of steroid receptor coactivators and methods of use thereof
#18972,4-pyrimidinediamine compounds and their uses
#1898Methods and systems for wireless to power line communication
#1899Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
#1900THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#1901Tetrahydroquinoline-based bromodomain inhibitors
#1902COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE
#1903ANTIVIRAL COMPOUNDS
#1904Benzene, Pyridine, and Pyridazine Derivatives
#1905Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
#1906Photoreactive ligands and uses thereof
#1907Pegylated carfilzomib compounds
#1908Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
#1909Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#1910ANTI-CANCER STEMNESS DRUGS
#1911Heterocyclic compounds as pesticides
#1912Pyrimidine derivatives for the treatment of viral infections
#1913Pyridine derivative
#1914Pyrimidinyloxy benzo-fused compounds as herbicides
#1915WDR5-MLL1 inhibitors and modulators
#1916MATERIALS FOR ORGANIC ELECTRONIC DEVICES
#1917Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof
#1918SPIRO-COMPOUNDS AS SIP MODULATORS
#1919Therapeutic compounds and uses thereof
#1920T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#1921MYC MODULATORS AND USES THEREOF
#1922Organic compound, and organic light emitting diode and organic light emitting display device including the same
#1923Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#1924COMPOUNDS WITH ARYLAMINE STRUCTURES
#1925SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS
#1926Theramutein modulators
#1927Compounds and methods for inhibiting fascin
#1928Modulators of chemokine receptors
#1929EZH2 inhibitors and uses thereof
#1930Forms of afatinib dimaleate
#1931Uracil containing compounds
#1932Deuterated N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl)-2-((4-ethylpiperazin-1-yl)methyl)quinoline-6-carboxamide
#1933Compounds, devices, and uses thereof
#1934CXCR4 CHEMOKINE RECEPTOR MODULATORS
#1935QUINOLINE AMINES USEFUL AS CYTOPROTECTIVE AGENTS
#1936SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#1937S1P modulating agents
#1938Neprilysin inhibitors
#1939SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE
#1940ARYL HYDROCARBON RECEPTOR (AHR) MODULATOR COMPOUNDS
#1941Arylation method
#1942Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#1943Pyrimidine prodrugs for the treatment of viral infections and further diseases
#1944MEK INHIBITORS AND METHODS OF THEIR USE
#1945Andrographolide derivatives and method of using the same for treatment or prevention of fibrosis
#19462-amino-5-oxyalkyl-pyrimidine derivatives and their use for controlling undesired plant growth
#1947Methods, systems, and apparatus for the monitoring, controlling, and communicating of electronic devices
#1948Anthelmintic quinoline-3-carboxamide derivatives
#1949Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
#1950Substituted pyridine and pyrazine compounds as PDE4 inhibitors
#1951ROR γ modulators
#1952PRODRUGS OF TETRAHYDROCANNABINOL, COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME
#1953EZH2 INHIBITORS FOR TREATING LYMPHOMA
#1954PRMT5 inhibitors and uses thereof
#1955Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#1956Methods for inhibiting fascin
#1957PYRIDAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
#1958Hydantoin containing deoxyuridine triphosphatase inhibitors
#1959AMPK-activating heterocyclic compounds and methods for using the same
#1960Compounds and compositions for inhibition of FASN
#1961Heterocyclic compound and use thereof
#1962TETRACYCLIC COMPOUND
#1963Neprilysin inhibitors
#1964INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#1965MATERIALS FOR ELECTRONIC DEVICES
#1966High heat monomers and methods of use thereof
#1967Heterocyclic amide compounds having RORyT inhibitory action
#1968TETRAHYDROPYRAN AND TETRAHYDROTHIOPYRAN AMIDE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
#1969Amino pyrimidine derivatives
#1970Pharmaceutically active compounds
#1971PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
#1972Urea derivative or pharmacologically acceptable salt thereof
#1973Imaging composition and uses thereof
#1974Heterocyclic derivatives for the treatment of cystic fibrosis
#1975Sulfoximine glycosidase inhibitors
#1976Dual mechanism inhibitors for the treatment of disease
#1977Heterocyclic compounds useful as dual ATX/CA inhibitors
#1978Aminopyrazine derivatives as PI3K-γ inhibitors
#1979Benzoimidazol-1,2-yl amides as Kv7 channel activators
#1980Phthalazinone derivatives
#1981Phenanthrene compounds for organic electronic devices
#1982COMPOSITIONS AND METHODS FOR QUADRICYCLANE MODIFICATION OF BIOMOLECULES
#1983Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#1984Inhibition of OLIG2 activity
#1985Pyrimidines and variants thereof, and uses therefor
#1986QUINOLONE-3-DIARYLETHERS
#1987Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
#1988Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophiles
#1989Substituted dihydrobenzofuran glycosidase inhibitors
#1990FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME
#19913-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
#1992GLP-1 receptor agonists and uses thereof
#1993GLP-1 receptor agonists and uses thereof
#1994Inhibitors of mechanotransduction to treat pain and modulate touch perception
#1995Tetrazolinone compounds and its use as pest control agents
#1996GLP-1 receptor agonists and uses thereof
#1997Bromodomain Inhibitors
#19981,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
#1999Phenyl substituted pyrazoles as modulators of RORγt
#2000Prodrugs of kallikrein inhibitors
#2001Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#2002Pyrazole derivatives as bromodomain inhibitors
#2003Germination promoters
#2004Inhibitors of RAD52 recombination protein and methods using same
#2005Process and crystalline forms of lumacaftor
#2006Amine-based compound and organic light-emitting device including the same
#2007Compounds for the treatment of HIV
#20083-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
#2009YAP1 inhibitors that target the interaction of YAP1 with OCT4
#2010Hepatitis B capsid assembly modulators
#2011Glycosidase inhibitors
#2012Quinazoline derivative
#2013ATF6 inhibitors and uses thereof
#20145-hydroxytryptamine receptor 7 activity modulators and their method of use
#2015Cyclopropane carboxamide modulators of cystic fibrosis transmembrane conductance regulator
#2016Heterocyclic compounds as pesticides
#2017Heterocyclic compounds as pesticides
#2018N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
#2019Heteroaromatic derivatives as NIK inhibitors
#2020SYNTHESIS OF RESORCYLIC ACID LACTONES USEFUL AS THERAPEUTIC AGENTS
#2021Inhibitors of bromodomain-containing protein 4 (BRD4)
#2022Sulfonylureas and related compounds and use of same
#2023Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
#20242,4-pyrimidinediamine compounds and their uses
#2025EBNA1 inhibitor crystalline forms, and methods of preparing and using same
#2026Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#2027Compounds useful for treating a or infection
#2028Heteroaromatic compound and organic electroluminescence device using the same
#2029Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosis
#2030Pyrrolidinone compounds
#2031CXCR3 RECEPTOR AGONISTS
#2032Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides
#2033POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE
#2034TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF
#2035Opioid receptor ligands and methods of using and making same
#2036Substituted guanidine compounds
#2037Antidiabetic spirochroman compounds
#2038Viral replication inhibitors
#2039Heteroaryl compounds and their use
#2040Amide compounds and use thereof
#2041Urea compound and preparation method and application thereof
#2042QUINOLINE SULFONAMIDES USEFUL TO TREAT DISEASE
#2043Diamine compound and organic light-emitting device including the same
#2044Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
#2045Benzopiperazine compositions as BET bromodomain inhibitors
#2046Substituted piperazines as selective HDAC1,2 inhibitors
#2047Kinase inhibitors
#2048Modulators of ROR-gamma
#2049Modulators of methyl modifying enzymes, compositions and uses thereof
#2050Modulators of ATP-binding cassette transporters
#2051Anticancer agent
#2052HIV replication inhibiting pyrimidines
#2053Agricultural chemicals
#2054Human plasma kallikrein inhibitors
#2055Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders
#2056GLUT4 Selective Inhibitors for Cancer Therapy
#2057Multi-substituted pyrimidine derivatives with excellent kinase inhibitory activities
#2058Combination therapy for treating cancer
#2059Bicyclic carboxamides and methods of use thereof
#2060Apelin receptor (APJ) agonists and uses thereof
#2061AN IMPROVED PROCESS FOR THE PREPARATION OF PAROXETINE AND ITS INTERMEDIATE
#2062Heterocyclic modulators of lipid synthesis
#2063Quinoxaline compounds as type III receptor tyrosine kinase inhibitors
#2064Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity
#2065Substituted quinazolines for inhibiting kinase activity
#2066Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
#2067FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS
#2068Sphinogosine-1 -phosphate receptor modulators for treatment of cardiopulmonary disorders
#2069Inhibitors of beta-hydroxylase for treatment of cancer
#2070Benzo-N-hydroxy amide compounds having antitumor activity
#2071Salt of quinazoline derivative, preparation method therefor and application thereof
#2072Use of compounds for making products with at least one N-halamine precursor group and at least one cationic center
#2073Binding Function 3 (BF3) site compounds as therapeutics and methods for their use
#2074Heterocyclic compounds for use in electronic devices
#2075THERAPEUTIC INHIBITORY COMPOUNDS
#2076Substituted quinoxaline DNA-PK inhibitors
#2077Aromatic amine derivatives and organic electroluminescent elements using same
#2078Materials for electronic devices
#2079Cyclic peroxides as prodrugs for selective delivery of agents
#2080Anticancer compounds
#2081NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#2082Deuterated CFTR modulators
#2083Substituted quinazoline compounds and methods of use thereof
#2084Substituted pyrimidines for preventing or treating cancer and inflammatory diseases
#2085Triazolone compounds as mPGES-1 inhibitors
#2086Antiviral compounds
#2087BLOCKERS OF THE GROWTH HORMONE RECEPTOR IN DISEASE PREVENTION AND TREATMENT
#2088Neprilysin inhibitors
#2089Substituted indazole compounds as RORgammaT inhibitors and uses thereof
#2090Aminopyrazine diol compounds as PI3K-γ inhibitors
#2091Tricyclic heterocyclic derivatives and uses thereof
#2092N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors
#2093Triazole furan compounds as agonists of the APJ receptor
#2094Bicyclic-fused heteroaryl or aryl compounds
#2095Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
#20961-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
#2097Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases
#2098Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide
#2099DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#2100HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS